Zurcher Kantonalbank (Zurich Cantonalbank) Caribou Biosciences, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 01, 2023	SELL	$5.57 - $11.01 $16,637 - $32,886	-2,987 Reduced 28.49%	7,498 $47,000
Q2 2022 Aug 09, 2022	BUY	$5.1 - $9.74 $53,473 - $102,123	10,485 New	10,485 $57,000

Others Institutions Holding CRBU

# of Institutions

135

Shares Held

52.6M

Call Options Held

148K

Put Options Held

70.7K

Black Rock Inc. New York, NY

6.95M
Shares

$12.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.62M
Shares

$8.31 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

4.57M
Shares

$8.23 Million
0.0% of portfolio
Pfm Health Sciences, LP San Francisco, CA

4.31M
Shares

$7.75 Million
0.49% of portfolio
Kynam Capital Management, LP Princeton, NJ

2.36M
Shares

$4.24 Million
0.38% of portfolio

View Full List

About Caribou Biosciences, Inc.

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $110M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

More about CRBU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account